Home Medicine STAT+: Congressional Medicare Advisors warn of higher drug costs despite recent price...

STAT+: Congressional Medicare Advisors warn of higher drug costs despite recent price negotiation

22
0



WASHINGTON — Despite the pharmaceutical industry’s loud complaints to the contrary, the new law directing Medicare to negotiate drug prices may increase prices for some new drugs, congressional Medicare advisers said Friday.

Stacie Dusetzina is a member the Medicare Payment Advisory Commission that advises Congress on Medicare policy. Although Medicare drug price negotiations get most of the attention. However, the Inflation Reduction Act also contains measures that make it easier to raise prices when companies launch drugs. Also, companies get to sell drugs for several years before they’re subject to Medicare negotiation.

Continue to STAT+ to read the full story…



Continue reading…

Previous articleWebb telescope was used by a team of scientists to discover a rocky planet Earth-sized.
Next articleAutumn Glory apple off to listing get started this season